Literature DB >> 12957360

Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines.

Marcia R Wink1, Guido Lenz, Elizandra Braganhol, Alessandra S K Tamajusuku, Gilberto Schwartsmann, João J F Sarkis, Ana M O Battastini.   

Abstract

In order to characterize the enzymes involved in the purine nucleotide catabolism as indicators of invasiveness and aggressiveness of malignant gliomas, the degradation of extracellular nucleotides by five different glioma cell lines was investigated and compared with primary astrocytes. Rapid hydrolysis of extracellular ATP and ADP by astrocytes was observed, whereas all glioma cell lines examined presented low rates of ATP hydrolysis. In contrast, ecto-5'-nucleotidase activity was increased in glioma cell lines when compared to astrocytes. Considering that ATP is recognized as a mitogenic factor that induces proliferation in human glioma cells, the substantial decrease in ATP and ADP hydrolysis observed in gliomas leads us to suggest that alterations in the ecto-nucleotidases pathway may represent an important mechanism associated with malignant transformation of glioma cell lines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957360     DOI: 10.1016/s0304-3835(03)00308-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  36 in total

1.  Blockade of CD73 delays glioblastoma growth by modulating the immune environment.

Authors:  J H Azambuja; R S Schuh; L R Michels; I C Iser; L R Beckenkamp; G G Roliano; G S Lenz; J N Scholl; J Sévigny; M R Wink; M A Stefani; A M O Battastini; F Figueiró; H F Teixeira; E Braganhol
Journal:  Cancer Immunol Immunother       Date:  2020-04-29       Impact factor: 6.968

2.  GL261 glioma tumor cells respond to ATP with an intracellular calcium rise and glutamate release.

Authors:  Averey D Strong; M Caitlin Indart; Nolan R Hill; Richard L Daniels
Journal:  Mol Cell Biochem       Date:  2018-01-09       Impact factor: 3.396

3.  Diminution in adenine nucleotide hydrolysis by platelets and serum from rats submitted to Walker 256 tumour.

Authors:  Andréia Buffon; Vanessa B Ribeiro; Alessandra S Schanoski; João J F Sarkis
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

4.  Methotrexate up-regulates ecto-5'-nucleotidase/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment.

Authors:  Fabrício Figueiró; Catiúscia P de Oliveira; Letícia S Bergamin; Liliana Rockenbach; Franciane B Mendes; Elisa Helena F Jandrey; Cesar Eduardo J Moritz; Letícia F Pettenuzzo; Jean Sévigny; Silvia S Guterres; Adriana R Pohlmann; Ana Maria O Battastini
Journal:  Purinergic Signal       Date:  2016-02-24       Impact factor: 3.765

5.  Extracellular ATP reduces tumor sphere growth and cancer stem cell population in glioblastoma cells.

Authors:  Pítia Flores Ledur; Emilly Schlee Villodre; Romela Paulus; Lavinia Almeida Cruz; Débora Gazzana Flores; Guido Lenz
Journal:  Purinergic Signal       Date:  2011-08-05       Impact factor: 3.765

6.  Overexpression of NTPDase2 in gliomas promotes systemic inflammation and pulmonary injury.

Authors:  Elizandra Braganhol; Rafael F Zanin; Andressa Bernardi; Leticia S Bergamin; Angelica R Cappellari; Luis F Campesato; Fernanda B Morrone; Maria M Campos; João B Calixto; Maria Isabel A Edelweiss; Márcia R Wink; Jean Sévigny; Simon C Robson; Ana Maria O Battastini
Journal:  Purinergic Signal       Date:  2011-10-30       Impact factor: 3.765

7.  P2Y14 receptor activation decreases interleukin-6 production and glioma GL261 cell proliferation in microglial transwell cultures.

Authors:  Marjorie A Curet; Jyoti J Watters
Journal:  J Neurooncol       Date:  2017-11-30       Impact factor: 4.130

8.  Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines.

Authors:  Fernanda B Morrone; Maria C Jacques-Silva; Ana P Horn; Andressa Bernardi; Gilberto Schwartsmann; Richard Rodnight; Guido Lenz
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

Review 9.  Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation.

Authors:  Scott A Friedle; Marjorie A Curet; Jyoti J Watters
Journal:  Recent Pat CNS Drug Discov       Date:  2010-01

10.  ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells.

Authors:  Nattinee Jantaratnotai; Hyun B Choi; James G McLarnon
Journal:  BMC Cancer       Date:  2009-12-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.